Betashares S&P Asx Australian Technology ETF logo

Betashares S&P Asx Australian Technology ETF (ATEC)

Market Open
- Market Cap
0% Div Yield
28,875 Volume
Earnings results expected in 41 days

Summary

ATEC trading today lower, a decrease of 1.87% from yesterday's close, completing a monthly decrease of -0.58%. Over the past 12 months, ATEC stock gained 0.75%.
ATEC is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2025, exceeded the consensus estimates by 0.06%. On average, the company has surpassed earnings expectations by 0.1%, based on the last three reports. The next scheduled earnings report is due on Jul 29, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track ATEC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bowman Secures Contract for ATEC Parkway Development in The Aurora Highlands, CO

Bowman Secures Contract for ATEC Parkway Development in The Aurora Highlands, CO

RESTON, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd.

Globenewswire | 4 weeks ago
Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript

Alphatec Holdings, Inc. (ATEC) Q1 2025 Earnings Call Transcript

Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Matt Miksic - Barclays Mathew Blackman - Stifel Young Li - Jefferies Eric Anderson - TD Cowen David Saxon - Needham Sean Lee - H.C. Wainwright Operator Good afternoon, everyone, and welcome to the webcast of ATEC's First Quarter Financial Results.

Seekingalpha | 1 month ago
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.34 per share a year ago.

Zacks | 1 month ago

Betashares S&P Asx Australian Technology ETF Dividends

ATEC is not paying dividends to its shareholders.

Betashares S&P Asx Australian Technology ETF Earnings

29 Jul 2025 (41 Days) Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS
25 Feb 2025 Date
-
Cons. EPS
-
EPS
4 Nov 2024 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS
ATEC is not paying dividends to its shareholders.
29 Jul 2025 (41 Days) Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS
25 Feb 2025 Date
-
Cons. EPS
-
EPS
4 Nov 2024 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS

Betashares S&P Asx Australian Technology ETF (ATEC) FAQ

On which exchange is it traded?

Betashares S&P Asx Australian Technology ETF is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is ATEC.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is -0.06.

When is the next earnings date?

The next earnings report will release on Jul 29, 2025.

Has Betashares S&P Asx Australian Technology ETF ever had a stock split?

Betashares S&P Asx Australian Technology ETF had 0 splits and the recent split was on Aug 25, 2016.

Betashares S&P Asx Australian Technology ETF Profile

CXA Exchange
US Country

Overview

Alphatec Holdings, Inc., founded in 1990 and headquartered in Carlsbad, California, is a distinguished medical technology company focused on the design, development, and commercialization of innovative technologies for the surgical treatment of spinal disorders. Operating both in the United States and internationally, Alphatec manufactures and supplies its revolutionary products through a combination of third-party suppliers, independent sales agents, and direct sales representatives. The company's commitment to advancing spinal surgery technologies has positioned it as a leader in its field, offering a wide range of solutions aimed at improving patient outcomes.

Products and Services

  • Alpha InformatiX Product Platform – A comprehensive suite of solutions that includes:
    • EOS imaging system: Offers full-body imaging for enhanced diagnostic capabilities.
    • VEA alignment mobile application: Leverages EOS technology, enabling quick quantification of alignment parameters on mobile devices.
    • SafeOp Neural InformatiX System: Automates electromyographic and somatosensory evoked potential monitoring for increased safety.
    • Valence: Integrates navigation and robotics into spine procedures, optimizing surgical outcomes.
  • Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems – Designed to improve accessibility and patient positioning during surgery.
  • Spinal Implants and Fixation Systems – Includes:
    • NanoTec surface modifications: Enhance implant integration and stability.
    • Calibrate PSX and Invictus: Offer advanced spinal fixation solutions.
    • Standalone implants: Provide options for height restoration and stabilization.
  • Biological Solutions – A diverse portfolio of biologics designed to support spinal surgery and healing, comprising:
    • 3D ProFuse Osteoconductive Bioscaffold: Facilitates ease of handling and improved endplate contact.
    • AlphaGRAFT Demineralized Bone Matrix (DBM): Utilizes demineralized human tissues for bone grafting.
    • AlphaGRAFT DBM Fibers: Offers demineralized fibers for versatile use in bone grafts.
    • AlphaGRAFT Cellular Bone Matrix (CBM): A growth factor-enriched cellular bone matrix available in various forms for different surgical needs.
    • BioCORE Moldable Bioactive Graft: A moldable, synthetic mineral-collagen composite matrix designed to fit bone defects.
    • Amnioshield Amniotic Tissue Barrier: An allograft used for spinal surgical barrier applications.

Contact Information

Address: 1950 Camino Vida Roble
Phone: 760 431 9286